A Study to Evaluate the Effect of Long-term Treatment with Drug X on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects.
A Study to Evaluate the Effect of Long-term Treatment with Drug X on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects.
A Trial Comparing Cardiovascular Safety of Insulin X Versus Insulin Y in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events.
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Daily Oral DRUG X and 50 mg Compared to Placebo When Used in Combination with DRUG Yin Subjects with Type 2 Diabetes, with Protocol number TAK-875_303.
Phase 2B Study on Safety and Therapeutic Efficacy of DRUG-X in Adult Subjects With Naturally Acquired Influenza.
A Randomized Open Label ,Parallel Group Multicenter Study To Determine The Efficacy And Long Term Safety Of Drug X Compared With Insulin In Subjects With T2DM.
A Randomized, Double Blind, Parallel Group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Drug X With Y And Z.
DORADO-Fixed doses of xxxxxx as compared to placebo in Resistant Hypertension .A phase 3 Randomized ,Double Blind ,Placebo –Controlled ,Muti-Center ,Parallel Group Study to Evaluate the Efficacy and Safety of Fixed Doses of xxxxx in Subjects with Resistant Systolic Hypertension Receiving Combination Therapy with four and more Antihypertensive Drugs,including Diuretic.
Inhaled Mealtime Insulin with the AERX IDMS Plus Drug P Versus DRUG P Alone In T2DM : A 26 Week ,Open Label Multicentered Randomized Parallel Trial To Investigate Safety And Efficacy.
Inhaled Mealtime Insulin with the AERX IDMS Plus Drug M Versus M & G versus R Plus M& G In T2DM : A 26 Week ,Open Label Multicentered Randomized Parallel Trial To Investigate Safety And Efficacy.
Comparison of Biphasic Insulin A Versus Insulin G in Subjects With Type 2 Diabetes.
Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Drug -M Only.
Long-term Study of N+V to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications.